Stock 6118 AUSTAR LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Austar Lifesciences Limited

Equities

6118

KYG0632L1023

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:05 2024-06-07 am EDT 		5-day change 1st Jan Change
0.74 HKD -3.90% Intraday chart for Austar Lifesciences Limited -9.76% -52.56%
Mar. 26 Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 22 Austar Lifesciences to Swing to Loss; Shares Drop MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,548 2,368 2,627 6,298 914.5 726.8
Enterprise Value (EV) 1 2,377 2,235 2,526 6,234 1,103 1,049
P/E ratio 23,894 x 293 x 85.4 x 22.8 x 10.5 x -6.4 x
Yield - - - - - -
Capitalization / Revenue 3.12 x 2.26 x 2.03 x 3.13 x 0.41 x 0.41 x
EV / Revenue 2.91 x 2.13 x 1.95 x 3.09 x 0.49 x 0.59 x
EV / EBITDA -1,007 x 114 x 58.5 x 47.7 x 10.4 x -52.9 x
EV / FCF -21.6 x 97 x -79.8 x -26.3 x -5.51 x -11.8 x
FCF Yield -4.63% 1.03% -1.25% -3.81% -18.2% -8.46%
Price to Book 5.3 x 4.79 x 5.07 x 8.01 x 1.02 x 0.94 x
Nbr of stocks (in thousands) 512,582 512,582 512,582 512,582 512,582 512,582
Reference price 2 4.970 4.620 5.126 12.29 1.784 1.418
Announcement Date 4/18/19 4/23/20 4/21/21 4/25/22 4/24/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 816.6 1,049 1,296 2,015 2,229 1,764
EBITDA 1 -2.361 19.54 43.18 130.6 106.1 -19.82
EBIT 1 -9.934 7.791 29.73 117 90.39 -41.21
Operating Margin -1.22% 0.74% 2.29% 5.8% 4.06% -2.34%
Earnings before Tax (EBT) 1 3.498 12.21 41.49 319.2 86.48 -34.41
Net income 1 0.107 8.091 33.1 277.3 87.46 -113.5
Net margin 0.01% 0.77% 2.55% 13.76% 3.92% -6.43%
EPS 2 0.000208 0.0158 0.0600 0.5400 0.1700 -0.2214
Free Cash Flow 1 -110 23.06 -31.65 -237.3 -200.2 -88.74
FCF margin -13.47% 2.2% -2.44% -11.78% -8.98% -5.03%
FCF Conversion (EBITDA) - 117.99% - - - -
FCF Conversion (Net income) - 284.95% - - - -
Dividend per Share - - - - - -
Announcement Date 4/18/19 4/23/20 4/21/21 4/25/22 4/24/23 4/25/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 188 322
Net Cash position 1 171 133 102 64.5 - -
Leverage (Debt/EBITDA) - - - - 1.776 x -16.27 x
Free Cash Flow 1 -110 23.1 -31.7 -237 -200 -88.7
ROE (net income / shareholders' equity) 0.02% 1.51% 6.15% 41.5% 8.1% -4.19%
ROA (Net income/ Total Assets) -0.64% 0.43% 1.46% 4.27% 2.55% -1.13%
Assets 1 -16.83 1,866 2,274 6,493 3,432 10,017
Book Value Per Share 2 0.9400 0.9600 1.010 1.530 1.750 1.510
Cash Flow per Share 2 0.3800 0.3700 0.3500 0.3900 0.2600 0.3200
Capex 1 5.19 13.7 26.5 101 117 69.2
Capex / Sales 0.64% 1.31% 2.05% 4.99% 5.26% 3.93%
Announcement Date 4/18/19 4/23/20 4/21/21 4/25/22 4/24/23 4/25/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
AUSTAR LIFESCIENCES LIMITED Stock Austar Lifesciences Limited
-52.56% 48.56M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.26% 187B
MEDTRONIC PLC Stock Medtronic plc
+2.05% 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.31% 69.54B
CENCORA, INC. Stock Cencora, Inc.
+14.65% 46.37B
DEXCOM, INC. Stock DexCom, Inc.
-6.69% 46.05B
HOYA CORPORATION Stock Hoya Corporation
+7.97% 42.54B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+18.60% 30.72B
TERUMO CORPORATION Stock Terumo Corporation
+16.92% 25.62B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-6.87% 23.32B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6118 Stock
  4. Financials Austar Lifesciences Limited